Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao(Shenzhen Bay Laboratory), Yu Chen(Guangdong Academy of Medical Sciences), Anuradha Gopalan(Memorial Sloan Kettering Cancer Center), Zhen Cao(Memorial Sloan Kettering Cancer Center), Ping Chi(Memorial Sloan Kettering Cancer Center), Peter T. Scardino(Memorial Sloan Kettering Cancer Center), Myriam Kossaï(Inserm), Theresa Y. MacDonald(NewYork–Presbyterian Hospital), Michael J. Morris(Dana-Farber Cancer Institute), Kristen Curtis(Memorial Sloan Kettering Cancer Center), Inna Sirota(Memorial Sloan Kettering Cancer Center), Phillip J. Iaquinta, Stephen B. Solomon(Memorial Sloan Kettering Cancer Center), Sinan Ramazanoglu(NewYork–Presbyterian Hospital), Catherine Dowling(Memorial Sloan Kettering Cancer Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Mark A. Rubin(University of Bern), Daniel C. Danila, Susan F. Slovin(Cornell University), Brett S. Carver(Memorial Sloan Kettering Cancer Center), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Vincent P. Laudone(Memorial Sloan Kettering Cancer Center), John Wongvipat(Memorial Sloan Kettering Cancer Center), Karim Touijer(Memorial Sloan Kettering Cancer Center), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Qi Fan Zhang(Memorial Sloan Kettering Cancer Center), Wei Di(Memorial Sloan Kettering Cancer Center), Vivek Arora(Bristol-Myers Squibb (Germany)), Ian Vela(Princess Alexandra Hospital), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Jackline Wanjala(Memorial Sloan Kettering Cancer Center), Eva A. Undvall(Memorial Sloan Kettering Cancer Center), Luendreo P. Barboza(Memorial Sloan Kettering Cancer Center), Juan‐Miguel Mosquera(NewYork–Presbyterian Hospital), James A. Eastham(Memorial Sloan Kettering Cancer Center), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Leili Ran(Memorial Sloan Kettering Cancer Center), Wouter R. Karthaus(École Polytechnique Fédérale de Lausanne)
Cited by 1,559
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k